|
ES2293638T3
(es)
|
1994-03-25 |
2008-03-16 |
Isotechnika, Inc. |
Mejora de la eficacia de farmacos por deuteracion.
|
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
US5543534A
(en)
|
1994-12-29 |
1996-08-06 |
Allergan |
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US6699849B1
(en)
|
1998-02-23 |
2004-03-02 |
Cyclops, Ehf. |
Cyclodextrin complexes of benzodiazepines
|
|
US6875619B2
(en)
|
1999-11-12 |
2005-04-05 |
Motorola, Inc. |
Microfluidic devices comprising biochannels
|
|
US20050009101A1
(en)
|
2001-05-17 |
2005-01-13 |
Motorola, Inc. |
Microfluidic devices comprising biochannels
|
|
ES2572030T3
(es)
|
2001-08-10 |
2017-07-19 |
Shionogi & Co., Ltd. |
Agente antiviral
|
|
AR037641A1
(es)
|
2001-12-05 |
2004-11-17 |
Tularik Inc |
Moduladores de inflamacion
|
|
WO2003063831A2
(en)
|
2002-02-01 |
2003-08-07 |
Pfizer Products Inc. |
Immediate release dosage forms containing solid drug dispersions
|
|
KR101076018B1
(ko)
|
2003-01-08 |
2011-10-21 |
유니버시티 오브 워싱톤 |
항균제
|
|
TW200510425A
(en)
|
2003-08-13 |
2005-03-16 |
Japan Tobacco Inc |
Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
|
|
TW200526635A
(en)
|
2003-12-22 |
2005-08-16 |
Shionogi & Co |
Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
|
|
WO2005110399A2
(en)
|
2004-04-29 |
2005-11-24 |
The Regents Of The University Of California |
Zinc-binding groups for metalloprotein inhibitors
|
|
WO2006028523A2
(en)
|
2004-04-29 |
2006-03-16 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO USDC Technology Transfer Office |
Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
|
|
WO2008027466A1
(en)
|
2006-08-31 |
2008-03-06 |
Schering Corporation |
Hydantoin derivatives useful as antibacterial agents
|
|
BRPI0720547A2
(pt)
|
2006-10-05 |
2014-05-06 |
Janssen Pharmaceutica Nv |
Inibidores de metaloprotease derivada de heterocíclico
|
|
TWI519508B
(zh)
|
2007-06-12 |
2016-02-01 |
Achaogen Inc |
抗菌劑
|
|
US8871728B2
(en)
*
|
2007-06-29 |
2014-10-28 |
Georgia Tech Research Corporation |
Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof
|
|
WO2010059838A2
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Pde4 inhibitors selective for the long form of pde4 for treating inflammation and avoiding side effects
|
|
IT1392249B1
(it)
|
2008-11-28 |
2012-02-22 |
Univ Degli Studi Urbino |
Derivati di [(3-idrossi-4-piron-2-il)metil]-amina e loro uso come farmaci anti-neoplastici
|
|
WO2010100475A1
(en)
|
2009-03-02 |
2010-09-10 |
Astrazeneca Ab |
Hydroxamic acid derivatives as gram-negative antibacterial agents
|
|
US9328075B2
(en)
|
2011-05-05 |
2016-05-03 |
St. Jude Children's Research Hospital |
Pyrimidinone compounds and methods for treating influenza
|
|
AU2012273100B2
(en)
|
2011-06-19 |
2017-05-25 |
Viamet Pharmaceuticals (NC), Inc. |
Metalloenzyme inhibitor compounds
|
|
US9394260B2
(en)
|
2012-04-03 |
2016-07-19 |
Bristol-Myers Squibb Company |
Pyrimidinone carboxamide inhibitors of endothelial lipase
|
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
|
KR20150039832A
(ko)
*
|
2012-08-06 |
2015-04-13 |
사피라 파르마슈티칼즈 게엠베하 |
디하이드록시피리미딘 탄산 유도체 및 바이러스성 질환의 치료, 개선 또는 예방에서의 이의 용도
|
|
AU2014209107B2
(en)
|
2013-01-28 |
2018-04-12 |
Viamet Pharmaceuticals (NC), Inc. |
Metalloenzyme inhibitor compounds
|
|
WO2014160649A1
(en)
*
|
2013-03-29 |
2014-10-02 |
Novartis Ag |
Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
|
|
US10647664B2
(en)
|
2013-08-16 |
2020-05-12 |
Duke University |
Substituted hydroxamic acid compounds
|
|
WO2015085238A1
(en)
|
2013-12-05 |
2015-06-11 |
The Regents Of The University Of California, A California Corporation |
Inhibitors of lpxc
|
|
WO2015099107A1
(ja)
|
2013-12-26 |
2015-07-02 |
塩野義製薬株式会社 |
含窒素６員環誘導体およびそれらを含有する医薬組成物
|
|
BR112017004798A2
(pt)
|
2014-09-12 |
2017-12-12 |
Toyama Chemical Co Ltd |
composição farmacêutica que contém um derivado de ácido hidroxâmico ou um seu sal
|
|
DK3233843T3
(da)
|
2014-12-16 |
2019-11-18 |
Novartis Ag |
Isoxazol-hydraxamsyreforbindelser som LPXC-hæmmere
|
|
CN105777464B
(zh)
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
EP3374350B1
(en)
|
2015-11-09 |
2022-01-05 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
WO2017083434A1
(en)
*
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Pyrone based compounds for treating bacterial infections
|
|
US10889556B2
(en)
|
2016-03-08 |
2021-01-12 |
The Regents Of The University Of California |
Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease
|
|
MX388647B
(es)
*
|
2016-12-23 |
2025-03-20 |
Intervet Int Bv |
Compuestos utiles para el tratamiento de una infeccion por mannheimia haemolytica o histophilus somni.
|
|
JPWO2018143162A1
(ja)
|
2017-01-31 |
2019-11-14 |
富士フイルム富山化学株式会社 |
ヒドロキサム酸のプロドラッグである化合物またはその塩、凍結乾燥製剤、ＬｐｘＣ阻害剤および抗菌剤
|
|
US11021471B2
(en)
|
2017-05-10 |
2021-06-01 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
WO2018208987A2
(en)
|
2017-05-10 |
2018-11-15 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
WO2018216822A1
(en)
|
2017-05-25 |
2018-11-29 |
Taisho Pharmaceutical Co., Ltd. |
Novel imidazole derivatives
|
|
WO2019086452A1
(en)
*
|
2017-10-31 |
2019-05-09 |
Idorsia Pharmaceuticals Ltd |
Antibacterial heteroaromatic compounds
|
|
BR112020016270A2
(pt)
|
2018-02-10 |
2020-12-15 |
Kbp Biosciences Co., Ltd. |
Composto atuando como antibióticos
|
|
AU2019345150A1
(en)
|
2018-09-20 |
2021-05-13 |
Blacksmith Medicines, Inc. |
Antibacterial compounds
|
|
WO2020102572A1
(en)
|
2018-11-14 |
2020-05-22 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
WO2021195258A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor, formulations, and uses thereof
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
WO2022086920A1
(en)
|
2020-10-20 |
2022-04-28 |
Blacksmith Medicines, Inc. |
Glutaminyl-peptide cyclotransferase like (qpctl) protein inhibitors and uses thereof
|
|
EP4291550A4
(en)
*
|
2021-02-11 |
2025-01-22 |
Blacksmith Medicines, Inc. |
Antibacterial compounds
|
|
AR124839A1
(es)
|
2021-02-11 |
2023-05-10 |
Forge Therapeutics Inc |
Compuestos antibacterianos
|
|
TW202322818A
(zh)
|
2021-09-28 |
2023-06-16 |
美商福吉醫療公司 |
Lpxc抑制劑及其用途
|
|
TW202417432A
(zh)
|
2022-08-10 |
2024-05-01 |
美商布萊克史密斯醫藥公司 |
抗菌化合物
|
|
WO2024036170A1
(en)
|
2022-08-10 |
2024-02-15 |
Blacksmith Medicines, Inc. |
Antibacterial compounds
|